TrialEuropean journal of clinical pharmacology2012

Dose-response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes.

Seiichi Hayato et al.PubMed ↗Publisher ↗

No numbers read from the abstract.